유럽 ​​Point-of-Care-Testing(POCT) 시장 – 2029년까지의 산업 동향 및 예측

유럽 ​​Point of Care Testing(POCT) 시장 분석 및 통찰력

진료 시점 검사(POCT)는 환자와 가까운 곳에서 실시할 수 있는 검사로, 결과와 모니터링을 포함하여 즉시 의학적 결정을 내릴 수 있습니다. 감염성 및 만성 질환의 유병률 증가, 진단 추구율 향상, 홈케어 검사 선호도 증가는 시장 성장을 견인하는 주요 요인 중 일부입니다.

그러나 실험실에서 얻은 시험 결과와의 불일치, 높은 비용, 숙련된 직원 부족 등은 시장 성장을 방해하는 과제 중 일부입니다.

유럽 ​​포인트 오브 케어 테스팅(POCT) 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 8.8%의 CAGR로 성장하고 있으며 2029년까지 13,085.33백만 달러에 도달할 것으로 분석합니다.

시장 정의

Point of Care Testing (POCT) is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within a few minutes as compared to hours. Currently, there are various products available that provide rapid and accurate results and help in patient’s better outcomes which is expected to provide various other opportunities for the market growth. However, lack of alignment in lab results and high cost of POCT products are expected to restrain the market growth in the forecast period.

Europe point of care testing (POCT) market report provides details of market share, new developments, product pipeline analysis and impact of domestic and localized market players that analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Point of Care Testing (POCT) Market Dynamics

Drivers

• Increasing prevalence of infectious and chronic diseases

The prevalence of infectious and chronic diseases such as cancer, diabetes and cardiovascular disorder is rapidly increasing across Europe. According to the World Health Organization (WHO), the contribution of chronic diseases was about 60% which accounted for the number of deaths. In Europe, the major reason behind the increasing number of chronic diseases is the increasing number of geriatric population. These increasing rates of the diseases are directly proportional to the market growth of POCT devices as they are used in the diagnosis of almost all diseases. We also know that as health degeneration begins with aging, the rate of chronic diseases and factors associated with them also increase with time. However, with increase in disease rate, the healthcare system and status of health is also improving due to awareness and adoption of POCT devices that help in the diagnosis of multiple chronic diseases thereby, driving the market growth.

For instance,

• In October 2017, according to a report published in Springer, 85% of deaths in the European Union (EU) were due to chronic diseases including cancer, cardiovascular disease, chronic respiratory disease, diabetes and mental illness

The growing incidences of chronic diseases in Europe with conditions like cancer, asthma and heart disease among others have improved the usage and awareness about early diagnosis of diseases. This awareness made people buy more healthcare premiums including whole body check-ups regularly that includes almost all the tests. At the same time, the population of chronic diseases is rapidly increasing.

 Thus, a major surge in the prevalence of chronic diseases will be acting as a major driver for the market growth as POCT devices can effectively manage the disorder and provide better comfort and treatment for monitoring whenever needed.

• Improved diagnosis-seeking rate

Improved healthcare professionals and regular training sessions for the professionals conducting tests have contributed to the improved diagnosis rates in the region, which includes an increase in the successful diagnosis of chronic diseases like cancer, cardiovascular disease, type 2 diabetes and others. The rate of diagnosis also increases as the burden of disease increases. Healthcare and IT professionals have the power to decrease the likelihood of error and are making attempts to increase the rate of seeking POCT. Along with that, they also help in determining and detecting the risk associated with it. Perhaps, to improve the rate of diagnosis the IT professionals evaluate the user experience also.

To support the POCT process, a methodology was introduced that includes coverage of management, time spent by professionals for diagnosis and evaluation activities that would help in improving the accuracy rate of the information and help in making better decisions in terms of diagnosis. Thus, the efforts by the healthcare and IT professionals, improved training of healthcare professionals, change in the patient care delivery system and improved diagnosis-seeking rate in the region are leading to the market growth.

• Rising preference for homecare testing

Increased demand for homecare testing results in reduced error and safety with ensured quality clinical information that will be available at appropriate time and location and also helps to understand the elder case of a medical emergency. The market has been growing due to rising geriatric population thereby, increasing the demand for homecare testing. With the help of cutting-edge modern technologies, home health care costs have been dramatically reduced and people are being helped effectively. Thus, increased preferences for home healthcare services will boost the demand for POCT devices driving the market growth.

Opportunity

• Strategic initiatives by the market players

The increase in the prevalence of chronic and infectious diseases in Europe requires new and advanced POCT kits and solutions with improved efficacy rate and reduced cycle time due to rise in the geriatric population and also to improve the healthcare management and diagnostics for quality performance. Major market leaders are engaged in full filling the demands of healthcare professionals and spending their time in research to produce better products, kits and reagents.

These strategic initiatives by the companies including acquisition and focused segment product launches are helping them to expand and enhance the product portfolio of the company which will ultimately lead to more revenue generation. Hence, these strategic initiatives by the market players are acting as an opportunity that is helping them to drive market growth.

Restraint/Challenge

• Lack of alignment with test results obtained from laboratories

The POCT results when compared with laboratory testing standards can differ and be performed by clinical personnel who are not trained in clinical laboratory sciences. The standardization and other essential criteria cannot be completed by POCT and this is acting as a major challenge for the market growth.

Given the advantages of POCT research, some downsides are not necessarily considered the safest choice. Owing to the sensitivity and precision associated with laboratory analyzers, clinical laboratory personnel are well aware of the analytical methodologies and are more reliable. In comparison, the test carried out by healthcare personnel rather than laboratory qualified persons resulted in mistakes arising from lack of awareness on the significance of quality management and quality assurance procedures. Thus, more precise and accurate results can be expected from laboratory testing as POCT faces challenges to meet all specific standards of testing due to lack of knowledge.

Recent Developments

• In May 2022, Abbott updated i-STAT software for hospitals and outpatient facilities to provide solution in real-time. The software consists of high efficacy rate, is cost-effective and provides good quality patient care decision-making
• In May 2022, EKF Diagnostics announced the launch of its new EKF Link digital connectivity solution for the secure management of POC analyzers and associated data on one centralized platform

Europe Point of Care Testing (POCT) Market Scope

Europe point of care testing (POCT) market is segmented into product, application, end user, mode of testing and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Instruments
• Consumables & Reagents
• Others

Based on product, the market is segmented into instruments, consumables & reagents and others.

Application

• Blood Glucose
• Cardiac Monitoring
• Coagulation
• Whole Blood Analysis
• Vital Sign Monitoring
• Infectious Disease Testing
• Urine Analysis
• Cholesterol Testing
• Others

Based on application, the market is segmented into blood glucose, cardiac monitoring, coagulation, whole blood analysis, vital sign monitoring, infectious disease testing, urine analysis, cholesterol testing and others.

End User

• Laboratories
• Hospitals
• Clinics
• Ambulatory Centers
• Home Care
• Assisted Living Facilities
• Pharmacies/Drug Stores
• Others

최종 사용자를 기준으로 시장은 실험실, 병원, 진료소, 외래진료센터, 가정 간병 시설, 보호시설, 약국/약국 및 기타로 구분됩니다.

테스트 모드

• 처방 기반 테스트
• OTC 테스트

테스트 방식을 기준으로 시장은 처방 기반 테스트와 OTC 테스트로 구분됩니다.

 유통 채널

• 직접 판매
• 제3자 유통업체
• 온라인 판매

유통 채널을 기준으로 시장은 직접 판매, 제3자 유통업체, 온라인 판매로 구분됩니다.

유럽 ​​Point of Care Testing(POCT) 시장 지역 분석/통찰력      

유럽 ​​진료소 검사(POCT) 시장을 분석하고, 제품, 응용 분야, 최종 사용자, 검사 방식 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

이 시장에서 다루는 국가는 독일, 프랑스, ​​영국, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 벨기에 및 기타 유럽 국가입니다. 독일은 시장 점유율과 시장 수익 측면에서 유럽 포인트 오브 케어 테스팅(POCT) 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 강화할 것입니다. 이는 유럽 지역에서 POCT 기기에 대한 인지도가 높아졌기 때문입니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 유럽 Point of Care Testing(POCT) 시장 점유율 분석

포인트 오브 케어 테스팅 시장 경쟁 구도는 경쟁자들의 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 회사의 포인트 오브 케어 테스팅 시장에 대한 초점과만 관련이 있습니다.

이 시장에서 활동하는 주요 기업으로는 Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Quidel Corporation Trividia Health, Inc., Nova Biomedical, PTS Diagnostics, Trinity Biotech, LumiraDx, Sekisui Diagnostics, Chembio Diagnostics, Inc., BD, Thermo Fisher Scientific Inc., Abbott, Danaher, binx health, Inc., QuantuMDx Group Ltd., Werfen, Thermo Fisher Scientific, Abaxis, EKF Diagnostics, Sysmex Europe SE 등이 있습니다.

SKU-33910